8-K
Current Report
Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-22-082266
Material agreement · Results of operations · Unregistered share sale · Code of ethics change
- Item 1.01 Entry into a material definitive agreement
- Item 2.02 Results of operations and financial condition
- Item 3.02 Unregistered sales of equity securities
- Item 5.05 Amendment to or waiver of the code of ethics
From the SEC's structured data for this filing
Loading tm2221625d1_8k.htm…